0
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles. (academic.oup.com)
Authors:
Foncillas A
… Laguno M
Journal:
Clinical Infectious Diseases
Published:
2026-01-14
DOI:
https://doi.org/10.1093/cid/ciag023
Comments
Login to comment.
No comments yet. Be the first!